» Articles » PMID: 30679491

TaME-seq: An Efficient Sequencing Approach for Characterisation of HPV Genomic Variability and Chromosomal Integration

Overview
Journal Sci Rep
Specialty Science
Date 2019 Jan 26
PMID 30679491
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

HPV genomic variability and chromosomal integration are important in the HPV-induced carcinogenic process. To uncover these genomic events in an HPV infection, we have developed an innovative and cost-effective sequencing approach named TaME-seq (tagmentation-assisted multiplex PCR enrichment sequencing). TaME-seq combines tagmentation and multiplex PCR enrichment for simultaneous analysis of HPV variation and chromosomal integration, and it can also be adapted to other viruses. For method validation, cell lines (n = 4), plasmids (n = 3), and HPV16, 18, 31, 33 and 45 positive clinical samples (n = 21) were analysed. Our results showed deep HPV genome-wide sequencing coverage. Chromosomal integration breakpoints and large deletions were identified in HPV positive cell lines and in one clinical sample. HPV genomic variability was observed in all samples allowing identification of low frequency variants. In contrast to other approaches, TaME-seq proved to be highly efficient in HPV target enrichment, leading to reduced sequencing costs. Comprehensive studies on HPV intra-host variability generated during a persistent infection will improve our understanding of viral carcinogenesis. Efficient identification of both HPV variability and integration sites will be important for the study of HPV evolution and adaptability and may be an important tool for use in cervical cancer diagnostics.

Citing Articles

A Review of Probe-Based Enrichment Methods to Inform Plant Virus Diagnostics.

Farrall T, Brawner J, Dinsdale A, Kehoe M Int J Mol Sci. 2024; 25(15).

PMID: 39125919 PMC: 11312432. DOI: 10.3390/ijms25158348.


HPV DNA Integration at Actionable Cancer-Related Genes Loci in HPV-Associated Carcinomas.

Sastre-Garau X, Estrada-Virrueta L, Radvanyi F Cancers (Basel). 2024; 16(8).

PMID: 38672666 PMC: 11048798. DOI: 10.3390/cancers16081584.


HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.

Yu L, Majerciak V, Lobanov A, Mirza S, Band V, Liu H mBio. 2024; 15(5):e0072924.

PMID: 38624210 PMC: 11077993. DOI: 10.1128/mbio.00729-24.


Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers.

Barra M, Chang M, Salcedo M, Schmeler K, Scheurer M, Maza M Anal Biochem. 2024; 688:115480.

PMID: 38331373 PMC: 11899860. DOI: 10.1016/j.ab.2024.115480.


A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care.

Chang M, Ma A, Novak E, Barra M, Kundrod K, Montealegre J Sci Rep. 2023; 13(1):20397.

PMID: 37989845 PMC: 10663460. DOI: 10.1038/s41598-023-47582-y.


References
1.
Meissner J . Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol. 1999; 80 ( Pt 7):1725-1733. DOI: 10.1099/0022-1317-80-7-1725. View

2.
Walboomers J, Jacobs M, Manos M, Bosch F, Kummer J, Shah K . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189(1):12-9. DOI: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. View

3.
Bosch F, Lorincz A, Munoz N, Meijer C, Shah K . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4):244-65. PMC: 1769629. DOI: 10.1136/jcp.55.4.244. View

4.
Zur Hausen H . Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002; 2(5):342-50. DOI: 10.1038/nrc798. View

5.
Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M . A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene. 2003; 22(25):3977-84. DOI: 10.1038/sj.onc.1206629. View